Fibrate | List of Frontiers open access articles

Original Research

Published on 13 Feb 2024

Fibrate and the risk of cardiovascular disease among moderate chronic kidney disease patients with primary hypertriglyceridemia

in Renal Endocrinology

Chieh-Li Yen
Pei-Chun Fan
Cheng-Chia Lee
Jia-Jin Chen
Chao-Yu Chen
Yi-Ran Tu
Pao-Hsien Chu
Ching-Chung Hsiao
Yung-Chang Chen
Chih-Hsiang Chang

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1333553

4,260 views
5 citations

Case Report

Accepted on 11 Feb 2026

Case report: Genetic testing reveals Wilson disease with familial hypertriglyceridemia in a 12-year-old boy

in Pediatric Gastroenterology, Hepatology and Nutrition

Yuemiao Wang
Daren Wu
Dandan Sun
Jiawei Wang
Xun Wang

Frontiers in Pediatrics

Original Research

Published on 22 Dec 2023

Flavonoids and fibrate modulate apoE4-induced processing of amyloid precursor protein in neuroblastoma cells

in Translational Neuroscience

Viralkumar Davra
Kenza E. Benzeroual

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1245895

3,844 views
4 citations

Review

Published on 23 Sep 2024

Sex differences in pathogenesis and treatment of dyslipidemia in patients with type 2 diabetes and steatotic liver disease

in Precision Medicine

Tatjana Ábel
Béla Benczúr
Éva Csajbókné Csobod

Frontiers in Medicine

doi 10.3389/fmed.2024.1458025

3,725 views
4 citations

Brief Research Report

Published on 20 Jan 2022

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study

in Gastrointestinal and Hepatic Pharmacology

Guilherme Grossi Lopes Cançado
Cláudia Alves Couto
Laura Vilar Guedes
Michelle Harriz Braga
Débora Raquel Benedita Terrabuio
Eduardo Luiz Rachid Cançado
Maria Lucia Gomes Ferraz
Cristiane Alves Villela-Nogueira
Mateus Jorge Nardelli
Luciana Costa Faria

Frontiers in Pharmacology

doi 10.3389/fphar.2021.818089

6,903 views
13 citations

Review

Published on 18 Mar 2025

Lipid abnormality in diabetic kidney disease and potential treatment advancements

in Diabetes: Molecular Mechanisms

Qian Ming Tu
Hui Min Jin
Xiu Hong Yang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1503711

10,705 views
18 citations

Original Research

Published on 15 Oct 2025

Circulating bile acids and HOMA-IR: cross-sectional results from the RoCAV population-based study

in Clinical Diabetes

Sarah Grossi
Emanuele Maria Giusti
Giovanni Veronesi
Simone Delaiti
Andrea Mancini
Laura Migliaccio
Selene Genova
Simona Costanzo
Kieran Michael Tuohy
Marco Mario Ferrario

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1656942

1,345 views
1 citation

Original Research

Published on 06 Feb 2025

Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database

in Predictive Toxicology

Qun Li
Wenya Shan
Saiwei Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1415701

7,601 views
2 citations

Original Research

Published on 07 Nov 2025

Assessing the real-world safety of fenofibric acid for hyperlipidemia: results from WHO-VigiAccess and FAERS databases

in Pathology

Yaxing Li
Yi Wang
Jidang Zhang
Ruonan Zhang
Zhiwen Yao
Xuepin Chen
Xingli Xu

Frontiers in Medicine

doi 10.3389/fmed.2025.1702197

1,940 views

Original Research

Published on 21 Feb 2024

COVID-19-associated hypertriglyceridemia and impact of treatment

in Infectious Diseases: Pathogenesis and Therapy

Rasha Kaddoura
Mohamed Izham Mohamed Ibrahim
Maha Al-Amri
Arun Prabhakaran Nair
Ahmad Alharafsheh
Sumaya Alsaadi Alyafei
Mutaz Albakri

Frontiers in Medicine

doi 10.3389/fmed.2024.1326156

3,141 views
2 citations

Original Research

Published on 09 Nov 2022

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

in General Cardiovascular Medicine

Wen-Yu Ho
Chieh-Li Yen
Cheng-Chia Lee
Yi-Ran Tu
Chao-Yu Chen
Ching-Chung Hsiao
Pao-Hsien Chu
Hsiang-Hao Hsu
Ya-Chun Tian
Chih-Hsiang Chang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.907539

3,925 views
4 citations

Articles

Fibrate and the risk of cardiovascular disease among moderate chronic kidney disease patients with primary hypertriglyceridemia

Case report: Genetic testing reveals Wilson disease with familial hypertriglyceridemia in a 12-year-old boy

Flavonoids and fibrate modulate apoE4-induced processing of amyloid precursor protein in neuroblastoma cells

Sex differences in pathogenesis and treatment of dyslipidemia in patients with type 2 diabetes and steatotic liver disease

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study

Lipid abnormality in diabetic kidney disease and potential treatment advancements

Circulating bile acids and HOMA-IR: cross-sectional results from the RoCAV population-based study

Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database

Assessing the real-world safety of fenofibric acid for hyperlipidemia: results from WHO-VigiAccess and FAERS databases

COVID-19-associated hypertriglyceridemia and impact of treatment

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study